skip to primary navigationskip to content

Cambridge Biorepository for Translational Medicine

Support for Multidisciplinary Translational Research

Studying at Cambridge

 

MedImmune

With 2200 global employees, MedImmune comprises almost half of AstraZeneca’s overall R&D portfolio and conducts research into Oncology, Respiratory, Inflammation, Autoimmune, Cardiovascular and Metabolic disease.

The Bradley Lab: 

The Bradley lab is currently working in collaboration with MedImmune and receiving tissue from the CBTM for the modelling of human glomerulosclerosis in vitro.